Gene therapy research regenerates optic nerve, bringing hope for future glaucoma treatment: Researchers have used gene therapy to regenerate damaged optic nerve fibres in a discovery that could help treat glaucoma, one of the world’s leading causes of blindness. The pre-clinical study, led by Professor Keith Martin from the Centre for Eye Research Australia and […]
Read More… from Glaucoma: gene therapy regenerates optic nerve
Genetic scissors: a tool for rewriting the code of life: The Nobel Prize in Chemistry 2020 The Royal Swedish Academy of Sciences has decided to award the Nobel Prize in Chemistry 2020 to Emmanuelle Charpentier Max Planck Unit for the Science of Pathogens, Berlin, Germany AND Jennifer A. Doudna University of California, Berkeley, USA “for the development […]
Read More… from Genetic scissors: a tool for rewriting the code of life
Researchers get a better grip on left and right handedness: In the largest study of its kind to date, researchers have identified 48 genetic variants that influence if a person is left-handed, right-handed or ambidextrous. The research led by QIMR Berghofer Medical Research Institute and The University of Queensland also confirmed that environment plays a […]
A genetic variant that protects against Alzheimer’s disease promotes immune cell functions: A new study conducted by researchers at the University of Eastern Finland found that the PLCG2-P522R genetic variant, which protects against Alzheimer’s disease, enhances several key functions of immune cells. The results obtained in the study highlight the importance of immune cells as […]
Read More… from Genetic variant protects against Alzheimer’s
World-renowned DNA expert heads University of Bradford cancer research institute – Institute develops medicines ‘from concept to clinic’ to tackle the ‘greatest challenges facing human health’ A world renowned expert on DNA has been appointed as the new Director of the University of Bradford’s Institute of Cancer Therapeutics (ICT) from August 3. Professor Sherif El-Khamisy’s research is […]
Aggressive cancers could be treated with immunotherapies that direct the immune system to kill cancer cells with specific drug resistance-causing mutations, a major new study suggests. Drug resistance mutations which restore activity of the BRCA1 or BRCA2 genes as a way of avoiding the effects of drug treatment could leave tumours vulnerable to the effects […]
Read More… from Immune system could be trained to spot drug-resistant cancers
People who are genetically predisposed to being overweight have a much harder time keeping their weight. A research team led by nutritional epidemiologist Leonie-Helen Bogl at MedUni Vienna’s Division of Epidemiology has conducted a specialised data analysis of a Finnish cohort study of twins and found that genetic risk factors influence eating behaviour. Especially the […]
Read More… from Genetics influence weight and eating behaviour
Scientists from the University of Bradford say they are ‘a step closer to finding a vaccine’ for tuberculosis after discovering a new variant of the disease in Africa. The new strain, known as Lineage 8, was found by chance in Rwanda – it has taken researchers two years to sequence and analyse its genome. The […]
Read More… from Tuberculosis: Scientists find “missing link” that moves them closer to cure
Imperial College London has formed a new social enterprise VacEquity Global Health (VGH) to bring its COVID-19 vaccine to the world. For the UK and low-income countries abroad, Imperial and VGH will waive royalties and charge only modest cost-plus prices to sustain the enterprise’s work, accelerate global distribution and support new research. The social enterprise’s […]
Read More… from Imperial social enterprise to accelerate low-cost COVID-19 vaccine
The Vaccines Manufacturing and Innovation Centre (VMIC), a not-for-profit organisation established to provide the UK’s first strategic vaccine development and advanced manufacturing capability has signed its first industry partnership agreement with gene and cell therapy group Oxford Biomedica plc. The agreement signed today involves the organisations collaborating to enable scaled-up manufacture of viral vector based […]
Read More… from Vaccines Manufacturing and Innovation Centre Signs First Industry Partnership